Sign in

CIK 0001582313

  • Large accelerated filer

Xenon Pharmaceuticals Inc.

Sign in to watch
Ticker
XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980661854
Phone
+1 604-484-3300
Business address
200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale Director sold 131,245 shares at an average $38.90 ($5,104,970)
  3. 4 Open-market sale PRESIDENT & CEO sold 31,655 shares at an average $41.41 ($1,310,931)
  4. 4 Open-market sale Chief Medical Officer sold 700 shares at $35.01 ($24,507)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale Director sold 19,232 shares at an average $36.98 ($711,199)
  13. 4 Exercise or conversion Director acquired 3,086 shares (option exercise)
  14. 4 Open-market sale Director sold 3,994 shares at an average $34.55 ($138,000)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale Chief Financial Officer sold 15,355 shares at $39.57 ($607,597)
  18. 4 Open-market sale EVP, Strategy & Innovation sold 65,231 shares at an average $38.31 ($2,499,023)
  19. 4 Open-market sale EVP, Drug Discovery sold 57,743 shares at an average $38.31 ($2,211,978)
  20. 4 Open-market sale Director sold 177,135 shares at an average $38.25 ($6,775,149)

Page 5 of 19 · 370 filings